NO980788L - Immunosuppressant - Google Patents
ImmunosuppressantInfo
- Publication number
- NO980788L NO980788L NO980788A NO980788A NO980788L NO 980788 L NO980788 L NO 980788L NO 980788 A NO980788 A NO 980788A NO 980788 A NO980788 A NO 980788A NO 980788 L NO980788 L NO 980788L
- Authority
- NO
- Norway
- Prior art keywords
- immunosuppressant
- formula
- optionally
- group
- atom
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
En immunosuppressant inneholdende som aktiv ingrediens en forbindelse representert ved formel(I): hvor Y er et nitrogenatom eller C-G (G er en eventuelt esterifisert eller amidert karbok- sylgruppe, en acylgruppe, en eventuelt beskyttet hydroksyalkylgruppe eller et halogen- atom); R er en eventuelt substituert hydrokarbonrest eller en eventuelt substituert heterocyklisk gruppe; X er et oksygenatom eller et eventuelt oksydert svovelatom; n er O eller l; k er O eller l; G og R kan binde seg sammen for å danne en ring; ringene A og B kan hver ha en substituent; eller et farmasøytisk salt derav. Det blir dessuten beskrevet en farmasøytisk sammensetning som omfatter en forbindelse representert ved formel (I) ovenfor eller et farmasøytisk akseptabelt salt derav og en immunosuppressant som er forskjellig fra forbindelsen med formel (I) ovenfor, og som er nyttig som en immunosuppressant.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23570495 | 1995-09-13 | ||
PCT/JP1996/001693 WO1997009984A1 (en) | 1995-09-13 | 1996-06-19 | Immunosuppressant |
Publications (2)
Publication Number | Publication Date |
---|---|
NO980788D0 NO980788D0 (no) | 1998-02-25 |
NO980788L true NO980788L (no) | 1998-03-31 |
Family
ID=16990000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO980788A NO980788L (no) | 1995-09-13 | 1998-02-25 | Immunosuppressant |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0850061A1 (no) |
KR (1) | KR19990044618A (no) |
CN (1) | CN1195988A (no) |
AU (1) | AU6137396A (no) |
BR (1) | BR9610314A (no) |
CA (1) | CA2226915A1 (no) |
HU (1) | HUP9900169A2 (no) |
NO (1) | NO980788L (no) |
NZ (1) | NZ310561A (no) |
WO (1) | WO1997009984A1 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0941987A1 (de) * | 1998-03-13 | 1999-09-15 | Lonza A.G. | Verfahren zur Herstellung von 2-Amino-4,5,3',4'-tetramethoxybenzophenon |
EP1086085A1 (en) | 1998-06-12 | 2001-03-28 | Vertex Pharmaceuticals Incorporated | INHIBITORS OF p38 |
EP1277740A1 (en) * | 1998-06-12 | 2003-01-22 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
DE19853487A1 (de) | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
BRPI0410805A (pt) | 2003-09-09 | 2006-06-27 | Fumapharm Ag | uso de derivados do ácido fumárico para tratamento da insuficiência cardìaca e asma |
HRP20220902T3 (hr) | 2007-02-08 | 2022-10-14 | Biogen Ma Inc. | Pripravci i njihova upotreba u liječenju multiple skleroze |
CN102050780B (zh) * | 2010-11-18 | 2012-05-02 | 中国科学院昆明植物研究所 | 喹啉衍生物,其药物组合物及其用途 |
WO2017151947A1 (en) * | 2016-03-02 | 2017-09-08 | George Robert Pettit | 4-azapodophylotoxins compounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3014099B2 (ja) * | 1987-08-26 | 2000-02-28 | バイオジェン インコーポレイテッド | 生物的材料、生物的材料の生産およびこの種の材料の治療への使用方法 |
KR0148009B1 (ko) * | 1988-05-27 | 1998-08-01 | 그래고리 비. 아보트 | 인터루킨-1 억제제 |
JP2863265B2 (ja) * | 1989-05-19 | 1999-03-03 | ハダサ メディカル オーガニゼーション | インターロイキン1インヒビター |
US6238875B1 (en) * | 1991-03-12 | 2001-05-29 | The Scripps Research Institute | Diagnostic methods useful in the characterization of lymphoproliferative disease characterized by increased EPR-1 |
TW232013B (no) * | 1992-04-24 | 1994-10-11 | Takeda Pharm Industry Co Ltd | |
US5646154A (en) * | 1992-10-07 | 1997-07-08 | Sumitomo Pharmaceuticals Co., Ltd. | Pharmaceutical compositions for inhibiting the formation of tumor necrosis factor |
JPH06340658A (ja) * | 1993-04-08 | 1994-12-13 | Kyowa Hakko Kogyo Co Ltd | ベンゾイミダゾール誘導体 |
IL111743A0 (en) * | 1993-12-08 | 1995-01-24 | Intermune Life Sciences Inc | Recombinant genes expressing pp14 |
-
1996
- 1996-06-19 HU HU9900169A patent/HUP9900169A2/hu unknown
- 1996-06-19 BR BR9610314A patent/BR9610314A/pt not_active Application Discontinuation
- 1996-06-19 WO PCT/JP1996/001693 patent/WO1997009984A1/en not_active Application Discontinuation
- 1996-06-19 CN CN96196854A patent/CN1195988A/zh active Pending
- 1996-06-19 NZ NZ310561A patent/NZ310561A/xx unknown
- 1996-06-19 KR KR1019980701869A patent/KR19990044618A/ko not_active Application Discontinuation
- 1996-06-19 AU AU61373/96A patent/AU6137396A/en not_active Abandoned
- 1996-06-19 EP EP96918849A patent/EP0850061A1/en not_active Withdrawn
- 1996-06-19 CA CA002226915A patent/CA2226915A1/en not_active Abandoned
-
1998
- 1998-02-25 NO NO980788A patent/NO980788L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP9900169A2 (hu) | 2000-03-28 |
NO980788D0 (no) | 1998-02-25 |
NZ310561A (en) | 1999-07-29 |
AU6137396A (en) | 1997-04-01 |
KR19990044618A (ko) | 1999-06-25 |
CA2226915A1 (en) | 1997-03-20 |
EP0850061A1 (en) | 1998-07-01 |
BR9610314A (pt) | 1999-07-06 |
CN1195988A (zh) | 1998-10-14 |
WO1997009984A1 (en) | 1997-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE202337T1 (de) | Cyclopropylalkansäurederivate | |
IL124537A0 (en) | Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same | |
NZ240676A (en) | Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof | |
ATE204857T1 (de) | Meta-substituierte phenylenderivate und ihre verwendung als alphavbeta3 intergrin-antagonisten oder inhibitoren | |
MY119820A (en) | Guanidine mimics as factor xa inhibitors | |
ATE164575T1 (de) | Substituierte aromatische verbindungen als c. amp phosphodiesterase-und tnf-hemmer | |
DK0894084T3 (da) | Kanelsyrederivater og deres anvendelse som integrinantagonister | |
HUP0203514A2 (hu) | Kinuklidin vegyületek és ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására | |
NO974734D0 (no) | Arylglycinamidderivater, fremgangsmåte for fremstilling av disse forbindelsene og farmasöytiske blandinger inneholdende slike forbindelser | |
NO306992B1 (no) | Quinolinderivater, farmasoeytiske preparater inneholdende forbindelsene og anvendelsen av forbindelsene | |
CA2275166A1 (en) | Novel benzopyran derivatives | |
RU94002335A (ru) | Производные хинолина или хиназолина и способ их получения | |
NO980788L (no) | Immunosuppressant | |
HUP9903459A2 (hu) | Oxa- és tiabiciklo[3.1.0]hexán-karbonsavak, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ATE48001T1 (de) | Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate. | |
NO307752B1 (no) | Nye hydroksimsyrederivater, farmasøytiske preparater inneholdende disse, og mellomprodukter for fremstilling derav | |
ES2132245T3 (es) | Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht. | |
MXPA02011352A (es) | Nuevos derivados de benzofurano. | |
NO993171L (no) | Substituerte propionylderivater | |
GB2341862A (en) | Histamine H3 receptor ligands | |
NO973103L (no) | Fremgangsmåte for inhibering av veksthormoneffekter | |
ES2039260T3 (es) | Derivado de 4-oxo-1,3-benzodioxano. | |
NZ329604A (en) | Isoxazole derivatives substituted by an amino, guanidinyl or azacycloalkyl-oxy, -sulphinyl or -sulphenyl group, pharmaceutical compositions comprising them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |